Owlet Inc
Owlet, Inc. provides digital parenting solutions in the United States, the United Kingdom, and internationally. The company offers a digital parenting platform that provides real-time data and insights to parents. It also provides sock monitors, including Dream Sock, a wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs, such as pulse rate, activity, oxy… Read more
Owlet Inc (OWLT) - Net Assets
Latest net assets as of December 2025: $35.40 Million USD
Based on the latest financial reports, Owlet Inc (OWLT) has net assets worth $35.40 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($85.60 Million) and total liabilities ($50.20 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $35.40 Million |
| % of Total Assets | 41.36% |
| Annual Growth Rate | N/A |
| 5-Year Change | -35.86% |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Owlet Inc - Net Assets Trend (2019–2025)
This chart illustrates how Owlet Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Owlet Inc (2019–2025)
The table below shows the annual net assets of Owlet Inc from 2019 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $35.40 Million | +267.39% |
| 2024-12-31 | $-21.15 Million | +28.74% |
| 2023-12-31 | $-29.68 Million | -179.04% |
| 2022-12-31 | $-10.63 Million | -119.27% |
| 2021-12-31 | $55.19 Million | +365.07% |
| 2020-12-31 | $-20.82 Million | -95.08% |
| 2019-12-31 | $-10.67 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Owlet Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24667600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.69 Million | 21.73% |
| Other Components | $335.58 Million | 947.97% |
| Total Equity | $35.40 Million | 100.00% |
Owlet Inc Competitors by Market Cap
The table below lists competitors of Owlet Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Metal Powder Works Ltd
AU:MPW
|
$85.38 Million |
|
Empire Metals Limited
OTCQB:EPMLF
|
$85.39 Million |
|
Westwater Resources Inc
NYSE MKT:WWR
|
$85.48 Million |
|
Pro-Hawk
TWO:8083
|
$85.48 Million |
|
Samyang Corp Preference Shares
KO:145995
|
$85.30 Million |
|
RattanIndia Enterprises Limited
NSE:RTNINDIA
|
$85.30 Million |
|
Graphite One Inc
OTCQX:GPHOF
|
$85.28 Million |
|
Sinar Mas Multiartha Tbk
JK:SMMA
|
$85.27 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Owlet Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -21,148,000 to 35,400,000, a change of 56,548,000.
- Net loss of 41,900,000 reduced equity.
- Other factors increased equity by 98,448,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-41.90 Million | -118.36% |
| Other Changes | $98.45 Million | +278.1% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Owlet Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 87.24x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-13.97 | $5.49 | x |
| 2020-12-31 | $-10.14 | $5.49 | x |
| 2021-12-31 | $7.01 | $5.49 | x |
| 2022-12-31 | $-1.34 | $5.49 | x |
| 2023-12-31 | $-3.59 | $5.49 | x |
| 2024-12-31 | $-1.40 | $5.49 | x |
| 2025-12-31 | $0.06 | $5.49 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Owlet Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -118.36%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -39.64%
- • Asset Turnover: 1.23x
- • Equity Multiplier: 2.42x
- Recent ROE (-118.36%) is below the historical average (-35.47%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -35.84% | 1.77x | 0.00x | $-16.78 Million |
| 2020 | 0.00% | -13.95% | 1.88x | 0.00x | $-8.44 Million |
| 2021 | -129.92% | -94.54% | 0.54x | 2.54x | $-77.22 Million |
| 2022 | 0.00% | -114.64% | 1.19x | 0.00x | $-78.27 Million |
| 2023 | 0.00% | -60.92% | 1.22x | 0.00x | $-29.93 Million |
| 2024 | 0.00% | -16.06% | 1.58x | 0.00x | $-10.42 Million |
| 2025 | -118.36% | -39.64% | 1.23x | 2.42x | $-45.44 Million |
Industry Comparison
This section compares Owlet Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Owlet Inc (OWLT) | $35.40 Million | 0.00% | 1.42x | $85.37 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |